Correlation Between Health Biotchnology and Eventide Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Eventide Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Eventide Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Eventide Healthcare Life, you can compare the effects of market volatilities on Health Biotchnology and Eventide Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Eventide Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Eventide Healthcare.

Diversification Opportunities for Health Biotchnology and Eventide Healthcare

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Health and Eventide is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Eventide Healthcare Life in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eventide Healthcare Life and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Eventide Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eventide Healthcare Life has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Eventide Healthcare go up and down completely randomly.

Pair Corralation between Health Biotchnology and Eventide Healthcare

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to generate 0.5 times more return on investment than Eventide Healthcare. However, Health Biotchnology Portfolio is 2.01 times less risky than Eventide Healthcare. It trades about -0.08 of its potential returns per unit of risk. Eventide Healthcare Life is currently generating about -0.08 per unit of risk. If you would invest  2,435  in Health Biotchnology Portfolio on October 23, 2024 and sell it today you would lose (98.00) from holding Health Biotchnology Portfolio or give up 4.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Eventide Healthcare Life

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Eventide Healthcare Life 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eventide Healthcare Life has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Health Biotchnology and Eventide Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Eventide Healthcare

The main advantage of trading using opposite Health Biotchnology and Eventide Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Eventide Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eventide Healthcare will offset losses from the drop in Eventide Healthcare's long position.
The idea behind Health Biotchnology Portfolio and Eventide Healthcare Life pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance